Literature DB >> 16026887

Corticosteroids for alcoholic hepatitis--what's next?

Philippe Mathurin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16026887     DOI： 10.1016/j.jhep.2005.06.003

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  10 in total

1.  Corticosteroid plus pentoxifylline is not better than corticosteroid alone for improving survival in severe alcoholic hepatitis (COPE trial).

Authors:  Sandeep Singh Sidhu; Omesh Goyal; Preeti Singla; Dinesh Gupta; Ajit Sood; Rajoo Singh Chhina; Ravinder Kumar Soni
Journal:  Dig Dis Sci       Date:  2012-03-03       Impact factor: 3.199

Review 2.  Early mortality of alcoholic hepatitis: a review of data from placebo-controlled clinical trials.

Authors:  Chao-Hui Yu; Cheng-Fu Xu; Hua Ye; Lan Li; You-Ming Li
Journal:  World J Gastroenterol       Date:  2010-05-21       Impact factor: 5.742

3.  Predicting short-term mortality and long-term survival for hospitalized US patients with alcoholic hepatitis.

Authors:  Jennifer A Cuthbert; Sami Arslanlar; Jay Yepuri; Marc Montrose; Chul W Ahn; Jessica P Shah
Journal:  Dig Dis Sci       Date:  2014-01-21       Impact factor: 3.199

Review 4.  Current concepts and controversies in the treatment of alcoholic hepatitis.

Authors:  Catherine Rongey; Neil Kaplowitz
Journal:  World J Gastroenterol       Date:  2006-11-21       Impact factor: 5.742

Review 5.  Alcoholic steatohepatitis: management and prognosis.

Authors:  Jacquelyn J Maher
Journal:  Curr Gastroenterol Rep       Date:  2007-03

Review 6.  Ethical and allocation issues in liver transplant candidates with alcohol related liver disease.

Authors:  Mai Sedki; Aijaz Ahmed; Aparna Goel
Journal:  Transl Gastroenterol Hepatol       Date:  2022-07-25

Review 7.  Current Management of Alcoholic Hepatitis and Future Therapies.

Authors:  Behnam Saberi; Alia S Dadabhai; Yoon-Young Jang; Ahmet Gurakar; Esteban Mezey
Journal:  J Clin Transl Hepatol       Date:  2016-06-15

8.  Alcoholic hepatitis and metabolic disturbance in female mice: a more tractable model than Nrf2 -/- animals.

Authors:  Lozan Sheriff; Reenam S Khan; Raquel Saborano; Richard Wilkin; Nguyet-Thin Luu; Ulrich L Gunther; Stefan G Hubscher; Philip N Newsome; Patricia F Lalor
Journal:  Dis Model Mech       Date:  2020-12-29       Impact factor: 5.758

9.  Cilostazol Decreases Ethanol-Mediated TNFalpha Expression in RAW264.7 Murine Macrophage and in Liver from Binge Drinking Mice.

Authors:  Youn Ju Lee; Jong Ryeol Eun
Journal:  Korean J Physiol Pharmacol       Date:  2012-04-24       Impact factor: 2.016

Review 10.  Focus on: Alcohol and the liver.

Authors:  Gyongyi Szabo; Pranoti Mandrekar
Journal:  Alcohol Res Health       Date:  2010
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.